These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 35502835)
1. Rhabdomyosarcoma With Epithelioid Features And Rakheja D; Park JY; Yang MS; Martinez DP; Koduru P; Wilson KS; Garcia R; Uddin N Int J Surg Pathol; 2023 Apr; 31(2):213-220. PubMed ID: 35502835 [TBL] [Abstract][Full Text] [Related]
2. FOXO1-FGFR1 fusion and amplification in a solid variant of alveolar rhabdomyosarcoma. Liu J; Guzman MA; Pezanowski D; Patel D; Hauptman J; Keisling M; Hou SJ; Papenhausen PR; Pascasio JM; Punnett HH; Halligan GE; de Chadarévian JP Mod Pathol; 2011 Oct; 24(10):1327-35. PubMed ID: 21666686 [TBL] [Abstract][Full Text] [Related]
3. PAX3/7-FOXO1 fusion status in older rhabdomyosarcoma patient population by fluorescent in situ hybridization. Dumont SN; Lazar AJ; Bridge JA; Benjamin RS; Trent JC J Cancer Res Clin Oncol; 2012 Feb; 138(2):213-20. PubMed ID: 22089931 [TBL] [Abstract][Full Text] [Related]
4. Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family. Sumegi J; Streblow R; Frayer RW; Dal Cin P; Rosenberg A; Meloni-Ehrig A; Bridge JA Genes Chromosomes Cancer; 2010 Mar; 49(3):224-36. PubMed ID: 19953635 [TBL] [Abstract][Full Text] [Related]
5. Genomic and clinical analysis of fusion gene amplification in rhabdomyosarcoma: a report from the Children's Oncology Group. Duan F; Smith LM; Gustafson DM; Zhang C; Dunlevy MJ; Gastier-Foster JM; Barr FG Genes Chromosomes Cancer; 2012 Jul; 51(7):662-74. PubMed ID: 22447499 [TBL] [Abstract][Full Text] [Related]
6. Alveolar rhabdomyosarcoma of the head and neck region in older adults: genetic characterization and a review of the literature. Yasuda T; Perry KD; Nelson M; Bui MM; Nasir A; Goldschmidt R; Gnepp DR; Bridge JA Hum Pathol; 2009 Mar; 40(3):341-8. PubMed ID: 18973919 [TBL] [Abstract][Full Text] [Related]
7. OLIG2 is a novel immunohistochemical marker associated with the presence of PAX3/7-FOXO1 translocation in rhabdomyosarcomas. Kaleta M; Wakulińska A; Karkucińska-Więckowska A; Dembowska-Bagińska B; Grajkowska W; Pronicki M; Łastowska M Diagn Pathol; 2019 Sep; 14(1):103. PubMed ID: 31493794 [TBL] [Abstract][Full Text] [Related]
8. Genomic and clinical analyses of 2p24 and 12q13-q14 amplification in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group. Barr FG; Duan F; Smith LM; Gustafson D; Pitts M; Hammond S; Gastier-Foster JM Genes Chromosomes Cancer; 2009 Aug; 48(8):661-72. PubMed ID: 19422036 [TBL] [Abstract][Full Text] [Related]
9. PAX3/FOXO1 fusion gene status is the key prognostic molecular marker in rhabdomyosarcoma and significantly improves current risk stratification. Missiaglia E; Williamson D; Chisholm J; Wirapati P; Pierron G; Petel F; Concordet JP; Thway K; Oberlin O; Pritchard-Jones K; Delattre O; Delorenzi M; Shipley J J Clin Oncol; 2012 May; 30(14):1670-7. PubMed ID: 22454413 [TBL] [Abstract][Full Text] [Related]
11. Survival outcomes of patients with localized FOXO1 fusion-positive rhabdomyosarcoma treated on recent clinical trials: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Heske CM; Chi YY; Venkatramani R; Li M; Arnold MA; Dasgupta R; Hiniker SM; Hawkins DS; Mascarenhas L Cancer; 2021 Mar; 127(6):946-956. PubMed ID: 33216382 [TBL] [Abstract][Full Text] [Related]
12. The PAX3-FOXO1 fusion protein present in rhabdomyosarcoma interferes with normal FOXO activity and the TGF-β pathway. Schmitt-Ney M; Camussi G PLoS One; 2015; 10(3):e0121474. PubMed ID: 25806826 [TBL] [Abstract][Full Text] [Related]
15. PAX3-FOXO1 fusion gene in rhabdomyosarcoma. Linardic CM Cancer Lett; 2008 Oct; 270(1):10-8. PubMed ID: 18457914 [TBL] [Abstract][Full Text] [Related]
16. Cryptic insertion of 3'FOXO1 into inverted chromosome arm 2q in the presence of two normal chromosome 13s and 13 small interstitial duplications in a patient with alveolar rhabdomyosarcoma. Hackman S; Calvey L; Bernreuter K; Mark MW; Starnes S; Batanian JR Cancer Genet; 2015 Sep; 208(9):428-33. PubMed ID: 26316324 [TBL] [Abstract][Full Text] [Related]
17. PAX3-FOXO1 is essential for tumour initiation and maintenance but not recurrence in a human myoblast model of rhabdomyosarcoma. Pandey PR; Chatterjee B; Olanich ME; Khan J; Miettinen MM; Hewitt SM; Barr FG J Pathol; 2017 Apr; 241(5):626-637. PubMed ID: 28138962 [TBL] [Abstract][Full Text] [Related]
18. SRF-FOXO1 and SRF-NCOA1 Fusion Genes Delineate a Distinctive Subset of Well-differentiated Rhabdomyosarcoma. Karanian M; Pissaloux D; Gomez-Brouchet A; Chevenet C; Le Loarer F; Fernandez C; Minard V; Corradini N; Castex MP; Duc-Gallet A; Blay JY; Tirode F Am J Surg Pathol; 2020 May; 44(5):607-616. PubMed ID: 32187044 [TBL] [Abstract][Full Text] [Related]
19. Detection of FOXO1 (FKHR) gene break-apart by fluorescence in situ hybridization in formalin-fixed, paraffin-embedded alveolar rhabdomyosarcomas and its clinicopathologic correlation. Mehra S; de la Roza G; Tull J; Shrimpton A; Valente A; Zhang S Diagn Mol Pathol; 2008 Mar; 17(1):14-20. PubMed ID: 18303411 [TBL] [Abstract][Full Text] [Related]
20. Modeling of the human alveolar rhabdomyosarcoma Pax3-Foxo1 chromosome translocation in mouse myoblasts using CRISPR-Cas9 nuclease. Lagutina IV; Valentine V; Picchione F; Harwood F; Valentine MB; Villarejo-Balcells B; Carvajal JJ; Grosveld GC PLoS Genet; 2015; 11(2):e1004951. PubMed ID: 25659124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]